Article
The emerging roles of NGS-based liquid biopsy in non-small cell lung cancer
23 Oct 2017
Abstract excerpt
The treatment paradigm of non-small cell lung cancer (NSCLC) has evolved into oncogene-directed precision medicine. Identifying actionable genomic alterations is the initial step towards precision medicine. An important scientific progress in molecular profiling of NSCLC over the past decade is the shift from the traditional piecemeal fashion to massively parallel sequencing with the use of next-generation...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
